NSE filing, NSE: NEPHROCARE. Summary written from the filing by ALFA Finder's alert engine.
Nephro Care India Ltd: key numbers
- Share price
- ₹80.75
- Market cap
- ₹133.1 Cr
- Revenue (annual)
- ₹88.73 Cr
- Net profit (annual)
- ₹3.37 Cr
- P/E (TTM)
- 39.5×Sector 52.0×
- Promoter holding
- 61.71%+0.00% QoQ
- FII holding
- 0.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nephro Care India Ltd
All →Nephro Care India Annual General Meeting
Nephro Care India Limited held its 12th Annual General Meeting on September 25, 2026. All resolutions proposed in the notice were passed by the members.
Nephro Care India Adverse Business Impact
Nephro Care India closes its Salt Lake, Kolkata dialysis unit from September 15, 2026 due to licensing constraints. Operations cease and premises will be vacated.
Nephro Care India Annual General Meeting
Nephro Care India Limited submitted its Annual Report for FY 2025-26 and the Notice for its 12th Annual General Meeting scheduled for September 25, 2026.
Nephro Care India Other Announcement
Nephro Care India Limited submitted its Statement of Deviation or Variation regarding IPO issue proceeds for the quarter ending June 30, 2026, confirming no deviations.
Nephro Care India Q1 FY27 Results: Net Profit ₹1.6 Cr, Up 60.0% YoY
Nephro Care India Ltd reported revenue from operations of ₹29.2 Cr (+9.4% YoY) and net profit of ₹1.6 Cr (+60.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.6 Cr · +60.0% YoY
Nephro Care India Legal & Regulatory
Nephro Care India Limited informs that SEBI corporate governance regulations do not apply to it for Q June 2026. The filing records this compliance exemption.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.